Back HIV Populations Women & HIV

Women & HIV

CROI 2012: Hormonal Contraception May Raise HIV Risk for Women, but Uncertainty Remains

Injectable hormonal contraception may raise the risk of HIV infection for women, but it does not appear to increase the risk of HIV disease progression in women with HIV, according to findings from 2 new studies presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle.alt

Read more:

WHO Affirms That Women at Risk for HIV Should Continue To Use Injectable Contraceptives

The World Health Organization (WHO) has affirmed its 2009 policy that women living with or at risk for HIV should continue to use hormonal contraception, despite conflicting results from recent studies suggesting that oral or injectable hormones may increase the risk of HIV infection.alt

Read more:

EACS 2011: Do Women with HIV Experience Earlier Menopause?

Premature menopause may be more common among women with HIV, but the difference is primarily driven by women with advanced immune deficiency, according to study results presented at the 13th European AIDS Conference (EACS 2011) this week in Belgrade.alt

Read more:

Pets and Parenthood Help Women Cope with HIV

Identification with their role as a mother, grandmother, or pet owner helped women with HIV cope with having a chronic disease, according to a study published in the January 2012 online edition of Women's Health Issues.alt

Read more:

Quad Pill Works as Well as Atazanavir Combo at 48 Weeks

The experimental Quad pill -- a once-daily single-tablet regimen containing the integrase inhibitor elvitegravir, the novel boosting agent cobicistat, and the NRTIs tenofovir and emtricitabine -- met a 48-week primary endpoint demonstrating non-inferiority to a boosted atazanavir regimen, Gilead Sciences announced this week. Both combinations suppressed HIV RNA in about 90% of treatment-naive HIV patients, but fewer people discontinued the Quad due to side effects. alt

Read more: